Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$1.08 - $1.55 $66,145 - $94,931
-61,246 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$1.35 - $2.95 $16,217 - $35,438
-12,013 Reduced 16.4%
61,246 $83,000
Q3 2021

Nov 15, 2021

BUY
$2.78 - $5.12 $34,280 - $63,134
12,331 Added 20.24%
73,259 $211,000
Q2 2021

Aug 16, 2021

BUY
$4.73 - $7.56 $3,859 - $6,168
816 Added 1.36%
60,928 $305,000
Q1 2021

May 14, 2021

BUY
$6.23 - $9.88 $374,497 - $593,906
60,112 New
60,112 $457,000

Others Institutions Holding AYTU

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About AYTU BIOPHARMA, INC


  • Ticker AYTU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 62,432,700
  • Market Cap $102M
  • Description
  • Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT f...
More about AYTU
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.